Is IMGN a Buy, Before Earnings?
PremiumPre-EarningsIs IMGN a Buy, Before Earnings?
7M ago
Immunogen Shareholders Approve Merger with AbbVie Inc.
Premium
Company Announcements
Immunogen Shareholders Approve Merger with AbbVie Inc.
8M ago
ImmunoGen’s Merger with AbbVie Awaits Shareholder Approval
Premium
Company Announcements
ImmunoGen’s Merger with AbbVie Awaits Shareholder Approval
8M ago
M & A News: AbbVie (NYSE:ABBV) Doubles Down on Acquisitions, Buys CERE for $8.7B
PremiumMarket NewsM & A News: AbbVie (NYSE:ABBV) Doubles Down on Acquisitions, Buys CERE for $8.7B
10M ago
ImmunoGen’s sBLA for Elahere in ovarian cancer granted priority review by FDA
Premium
The Fly
ImmunoGen’s sBLA for Elahere in ovarian cancer granted priority review by FDA
10M ago
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
Premium
The Fly
ImmunoGen downgraded to Neutral from Overweight at Piper Sandler
10M ago
ImmunoGen downgraded to Neutral from Buy at Guggenheim
PremiumThe FlyImmunoGen downgraded to Neutral from Buy at Guggenheim
10M ago
ImmunoGen downgraded to Market Perform from Outperform at BMO Capital
Premium
The Fly
ImmunoGen downgraded to Market Perform from Outperform at BMO Capital
10M ago
ImmunoGen downgraded to Hold from Buy at Deutsche Bank
Premium
The Fly
ImmunoGen downgraded to Hold from Buy at Deutsche Bank
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100